Dementia Research Section and Memory Clinic, Alzheimer Memorial Center, Department of Psychiatry, Ludwig-Maximilian University, Nussbaumstrasse 7, D-80366 Munich, Germany.
Nat Rev Neurol. 2010 Sep;6(9):508-17. doi: 10.1038/nrneurol.2010.113. Epub 2010 Aug 17.
Alzheimer disease (AD) is one of the most prevalent chronic medical conditions affecting the elderly population. The effectiveness of approved antidementia drugs, however, is limited-licensed AD medications provide only moderate relief of clinical symptoms. Cognitive intervention is a noninvasive therapy that could aid prevention and treatment of AD. Data suggest that specifically designed cognitive interventions could impart therapeutic benefits to patients with AD that are associated with substantial biological changes within the brain. Moreover, evidence indicates that a combination of pharmacological and non-pharmacological interventions could provide greater relief of clinical symptoms than either intervention given alone. Functional and structural MRI studies have increased our understanding of the underlying neurobiological mechanisms of aging and neurodegeneration, but the use of neuroimaging to investigate the effect of cognitive intervention on the brain remains largely unexplored. This Review provides an overview of the use of cognitive intervention in the healthy elderly population and patients with AD, and summarizes emerging findings that provide evidence for the effectiveness of this approach. Finally, we present recommendations for future research on the use of cognitive interventions in AD and discuss potential effects of this therapy on disease modification.
阿尔茨海默病(AD)是影响老年人群体的最常见慢性疾病之一。然而,已批准的抗痴呆药物的疗效有限——许可的 AD 药物仅能适度缓解临床症状。认知干预是一种非侵入性疗法,可有助于 AD 的预防和治疗。有数据表明,专门设计的认知干预可能会给 AD 患者带来治疗益处,这些益处与大脑内的实质性生物学变化有关。此外,有证据表明,与单独使用任何一种干预措施相比,药物和非药物干预的联合使用可以更有效地缓解临床症状。功能和结构磁共振成像研究增加了我们对衰老和神经退行性变的潜在神经生物学机制的理解,但神经影像学在研究认知干预对大脑的影响方面的应用仍在很大程度上未被探索。这篇综述概述了认知干预在健康老年人和 AD 患者中的应用,并总结了提供该方法有效性证据的新发现。最后,我们提出了在 AD 中使用认知干预的未来研究建议,并讨论了这种疗法对疾病修饰的潜在影响。